PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7912292-8	1994	Dexamethasone (10(-7) M) treatment resulted in a 3-fold reduction in PRL mRNA and CgB mRNA, whereas GH and Sg II mRNAs were both increased after dexamethasone treatment.	Dexamethasone	145-158	growth hormone	Mus musculus	100-102	
8781547-8	1996	Dexamethasone showed a potential as an inducer at more than 10(-8) M. Sex hormones increased the expression of this P-450 species a little in culture, but growth hormone did not.	Dexamethasone	0-13	growth hormone	Mus musculus	155-169	
12746318-0	2003	Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice.	Dexamethasone	0-13	growth hormone	Mus musculus	52-66	
11798186-3	2002	Interestingly, treatment of 3T3-L1 cells with 100 nM insulin, 10 ng/ml tumor necrosis factor (TNF) alpha, or 100 nM dexamethasone for 16 h suppressed adiponectin gene expression by about 50 to 85% while angiotensin 2, growth hormone, and triiodothyronine did not have any effect.	Dexamethasone	116-129	growth hormone	Mus musculus	218-232	
7912292-10	1994	CONCLUSIONS: This stable transgenic cell line is regulated by estradiol and dexamethasone with changes in PRL, GH, and Cg/Sg mRNA transcript levels.	Dexamethasone	76-89	growth hormone	Mus musculus	111-113	
1422974-2	1992	The purpose of this study was to examine the possible prevention by GH of the damage inflicted by dexamethasone (Dex) at sites of skeletal growth and ossification.	Dexamethasone	98-111	growth hormone	Mus musculus	68-70	
1422974-2	1992	The purpose of this study was to examine the possible prevention by GH of the damage inflicted by dexamethasone (Dex) at sites of skeletal growth and ossification.	Dexamethasone	113-116	growth hormone	Mus musculus	68-70